Ceftazidime-Avibactam Susceptibility Patterns of Carbapenem-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa Clinical Strains in a Tertiary-Care Educational Hospital in Türkiye

Ceftazidime-Avibactam Susceptibility Patterns of Carbapenem-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa Clinical Strains in a Tertiary-Care Educational Hospital in Türkiye

Bibliographic Details
Main Authors:	Ayşe NOYAN, Oğuz Reşat SİPAHİ, Feriha ÇİLLİ, Şöhret AYDEMİR
Format:	Article
Language:	English
Published:	Bilimsel Tip Yayinevi 2024-03-01
Series:	Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Online Access:	http://floradergisi.org/managete/fu_folder/2024-01/2024-29-01-161-163.pdf

Similar Items

Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China
by: Yiwei Zhu, et al.
Published: (2021-12-01)

Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae
by: Jie Gu, et al.
Published: (2021-09-01)

Ceftazidime/Avibactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Infection in Lung Transplant Recipients
by: Chen J, et al.
Published: (2023-04-01)

Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant Pseudomonas aeruginosa Infection
by: Chen J, et al.
Published: (2022-02-01)

Carbapenem-Resistant Klebsiella pneumoniae Osteomyelitis Treated with Ceftazidime-Avibactam in an Infant: A Case Report
by: Ji Z, et al.
Published: (2021-08-01)

Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae Due to In-Host Microevolution
by: Xinhong Han, et al.
Published: (2021-10-01)

Ceftazidime/Avibactam Resistance in Carbapenemase-Producing Klebsiella pneumoniae
by: Qiaozhen Cui, et al.
Published: (2023-11-01)

In vitro activity of ceftazidime-avibactam, imipenem-relebactam, aztreonam-avibactam, and comparators toward carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates
by: Dan Li, et al.
Published: (2023-12-01)

Prevalence and molecular characteristics of ceftazidime-avibactam resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates
by: Yili Chen, et al.
Published: (2024-03-01)

Carbapenem-Resistant Pseudomonas aeruginosa Spondylodiscitis Treated with Ceftazidime-Avibactam: A Case Report with Literature Review
by: Danda GJDN, et al.
Published: (2023-08-01)

In Vitro Activity of Ceftolozane/tazobactam and Ceftazidime/avibactam Against Carbapenemase-producing Pseudomonas aeruginosa
by: Özlem AYDEMİR, et al.
Published: (2019-12-01)

Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
by: Wenqiang Kong, et al.
Published: (2023-02-01)

Comparison of Etest and broth microdilution for evaluating the susceptibility of Staphylococcus aureus and Streptococcus pneumoniae to ceftaroline and of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa to ceftazidime/avibactam
by: Yu-Tsung Huang, et al.
Published: (2021-09-01)

Case series; Ceftazidime/avibactam for treating post-neurosurgical ventriculitis and meningitis due to Carbapenem-resistant Klebsiella pneumonia (CRKP)
by: Sajan Pandey, et al.
Published: (2023-12-01)

Combination Therapy of Ceftazidime/Avibactam for the Treatment of Patients Infected with Carbapenem-Resistant Klebsiella pneumoniae: A Multicenter Retrospective Study
by: Jing Lin, et al.
Published: (2023-09-01)

Molecular Mechanisms Mediating Ceftazidime/Avibactam Resistance Amongst Carbapenem-Resistant Klebsiella pneumoniae Isolates from Cancer Patients
by: El-Kady RAE, et al.
Published: (2022-10-01)

Evaluation of Ceftazidime-Avibactam Resistance Rates in Multi-Drug Resistant Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa Strains in Intensive Care Units
by: Fatih KAYA, et al.
Published: (2024-03-01)

Comparison of antimicrobial activity between ceftolozane–tazobactam and ceftazidime–avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa
by: Adnan Alatoom, et al.
Published: (2017-09-01)

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i>
by: George L. Daikos, et al.
Published: (2021-09-01)

Resistance Genes and Molecular Epidemiology in Ceftazidime-Avibactam-Resistant Pseudomonas aeruginosa Isolates
by: Neslihan ARICI, et al.
Published: (2023-10-01)

Emergence of a KPC-90 Variant that Confers Resistance to Ceftazidime-Avibactam in an ST463 Carbapenem-Resistant Pseudomonas aeruginosa Strain
by: Yuexing Tu, et al.
Published: (2022-02-01)

Emergence of Ceftazidime–Avibactam Resistance and Decreased Virulence in Carbapenem-Resistant ST11 Klebsiella pneumoniae During Antibiotics Treatment
by: Xu M, et al.
Published: (2022-11-01)

Identification of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam from ST11 Carbapenem-Resistant Klebsiella pneumoniae Strains
by: Yuchen Wu, et al.
Published: (2022-04-01)

Review of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem-Vaborbactam and Imipenem-Relebactam in Carbapenemase Producing Klebsiella pneumoniae Isolates
by: Özlem AYDEMİR, et al.
Published: (2023-09-01)

In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany
by: Michael Kresken, et al.
Published: (2021-06-01)

Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing Klebsiella pneumoniae From Patients Without Ceftazidime-Avibactam Use History – A Multicenter Study in China
by: Xiaoyan Cui, et al.
Published: (2020-06-01)

The Rapid Emergence of Ceftazidime-Avibactam Resistance Mediated by KPC Variants in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in Zhejiang Province, China
by: Congcong Liu, et al.
Published: (2022-05-01)

In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review
by: Abdullah Tarık Aslan, et al.
Published: (2023-09-01)

Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature
by: Ángela Cano, et al.
Published: (2020-09-01)

Community-acquired bacteraemia by Klebsiella pneumoniae producing KPC-3 and resistant to ceftazidime/avibactam
by: Isabel Machuca, et al.
Published: (2022-09-01)

MIC profiling of ceftazidime/avibactam against two carbapenemase-producing Klebsiella pneumoniae isolates
by: Andrei Zidaru, et al.
Published: (2020-12-01)

In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae
by: Wenxia Zhang, et al.
Published: (2018-11-01)

In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Marta Palombo, et al.
Published: (2023-12-01)

Clinical Outcomes and Risk Factors for Death in Critically Ill Patients with Carbapenem-Resistant Klebsiella pneumoniae Treated with Ceftazidime-Avibactam: A Retrospective Study
by: Zhang L, et al.
Published: (2024-01-01)

Ceftazidime/Avibactam, Polymyxin or Tigecycline as a Rescue Strategy for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae in Bloodstream Infection: A Retrospective Cohort Study
by: Fang Y, et al.
Published: (2023-05-01)

Emergence of ceftazidime-avibactam resistance due to a novel blaKPC-2 mutation during treatment of carbapenem-resistant Klebsiella pneumoniae infections
by: Quanfeng Liao, et al.
Published: (2022-05-01)

Emergence of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in a Widespread ST11 Carbapenem-Resistant Klebsiella pneumoniae Clone in China
by: Xi Li, et al.
Published: (2021-08-01)

Molecular Mechanisms Driving the In Vivo Development of KPC-71-Mediated Resistance to Ceftazidime-Avibactam during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
by: Xi Li, et al.
Published: (2021-12-01)

Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates
by: María M. Montero, et al.
Published: (2021-09-01)

Synergistic Activity of Imipenem in Combination with Ceftazidime/Avibactam or Avibactam against Non-MBL-Producing Extensively Drug-Resistant Pseudomonas aeruginosa
by: Yulin Zhang, et al.
Published: (2022-04-01)